ReGen seeks more capital; positive results on anti-ageing, cancer
ReGen Therapeutics is seeking shareholder go-ahead to issue more shares and/or securities to facilitate potential future fundraisings and fund acquisition of complementary businesses; and has reported positive findings in a study on Colostrinin's...